Mr. Bandy is the President and Chief Executive Officer of ReShape Lifesciences Inc. Mr. Bandy has extensive leadership experience in health care and specifically in the obesity and bariatric space. Most recently, Mr. Bandy was President and Chief Executive Officer of BroadSpot Imaging Corporation, a developer of medical devices for eye care, since April 2017. From April 2013 to August 2013, Mr. Bandy was President of the Wellness division at Alphaeon Corporation, where he was responsible for business development, commercial activities, strategy and acquisition integration. He previously spent 10 years at Inamed and Allergan leading their Health divisions, through the acquisition by Allergan.
Mr. Youngstrom is the Senior Vice President, Finance and has served as Chief Financial Officer since October 2016. Mr. Youngstrom has over 25 years of strategic financial and operational experience in a variety of medical device companies, most recently having served as Chief Financial Officer and Vice President, Finance at Galil Medical, a leading developer of cryotherapy technology. Prior to Galil Medical, Mr. Youngstrom served as Vice President, Chief Operating Officer, and Chief Financial Officer at DGIMED Ortho, Inc., a developer of orthopedic medical devices. Mr. Youngstrom has previously served as Chief Financial Officer and Vice President, Finance with Anulex Technologies, Enpath Medical, Compex Technologies, Acist Medical Systems, and Cardiotronics.
Dr. Nihalani has served as Chief Technology Officer since May 2017, immediately following the Company’s acquisition of BarioSurg, Inc. From August 2008 to May 2017, Dr. Nihalani served as the Chief Executive Officer of BarioSurg, Inc., a privately held medical device company that developed a minimally invasive and reversible device to treat obesity and glycemic control. Dr. Nihalani holds a medical degree from the University of Nagpur, India.
Mr. Ansari joined the Company as Senior Vice President of Sales in January 2016. Since the acquisition of ReShape Medical, Inc. in October 2017, Mr. Ansari has assumed the position of Vice President of International Sales and US Veterans Administration Hospitals. Mr. Ansari has over 20 years of experience in the medical device industry, having held various senior sales positions at Stryker Corporation, DePuy, Medtronic, Inc., Lanx, Inc., and Globus Medical, Inc. Prior to joining the Company, Mr. Ansari spent two years as the owner of an independent distributor solely selling Biomet products. Prior to this, he served as Senior Vice President of Sales at Lanx, Inc.
Ms. Schmalz has served as Vice President of Regulatory Affairs, Clinical Research, and Compliance since October 2017. Ms. Schmalz has over 25 years of executive leadership experience in medical device regulatory affairs, clinical research, compliance, and reimbursement. Ms. Schmalz served as a member of the executive team for Empi, Inc., Vascular Solutions, Entellus Medical, Veniti, and most recently served as Senior Director and Executive Director of the Medical Device Division of Medpace from May 2013 to October 2017.
Mr. Shah joined the Company as Vice President of Operations and R&D in February 2018. With more than 18 years of experience in medical device manufacturing management, global supply chain, and information technology, he brings the business and technical requirements needed to ensure effective leadership and management. Prior to joining ReShape Lifesciences, Mr. Shah served as Vice President of Manufacturing and Operations at Presbia, where he oversaw global operations and manufacturing for optical medical device products, established the company’s manufacturing facility, and developed OEM overseas manufacturing. He has also held positions as Director of Manufacturing/Supply Chain for BiovisionAG/Visitome, Global Planning System Analyst at CooperVision, and Operations/IT Manager for Ocular Sciences.